Associated Ulcerative Colitis, Sclerosing Cholangitis, and Insulin*Dependent Diabetes Mellitus

Total Page:16

File Type:pdf, Size:1020Kb

Associated Ulcerative Colitis, Sclerosing Cholangitis, and Insulin*Dependent Diabetes Mellitus CASE REPORT Associated ulcerative colitis, sclerosing cholangitis, and insulin*dependent diabetes mellitus MARSHA KAY, MD; ROBERT WYLLIE, MD; WILLIAM MICHENER, MD; MAUREEN CAULFIELD, MD; RITA STEFFEN, MD LINICALLY symptomatic We report two young men with clinical and laboratory evidence ulcerative colitis, sclero- of macroscopic ulcerative colitis, sclerosing cholangitis, and insu- sing cholangitis, and in- lin-dependent diabetes mellitus. The first patient presented at age Csulin-dependent diabe- 15 with vomiting, abdominal pain, weight loss, and abnormal tes mellitus have not previously liver function test results. Liver biopsy and endoscopic retrograde been reported in the same patient. cholangiopancreatography (ERCP) demonstrated sclerosing cho- Although each may be associated langitis. Colonoscopy with biopsy revealed ulcerative colitis with the other, their occurrence in which responded to sulfasalazine. Diabetes occurred at age 18 and the same individual implies a com- insulin therapy was begun. mon susceptibility, perhaps involv- The second patient was 19 at presentation with diarrhea, hema- ing the immune system. We have tochezia, and weight loss. Proctosigmoidoscopy revealed identified two patients with each ulcerative colitis, and sulfasalazine led to clinical remission. Three of these disorders. These two months later he developed diabetes requiring insulin therapy. At young men were followed up at age 28, he developed elevated alkaline phosphatase, and ERCP re- The Cleveland Clinic Foundation vealed sclerosing cholangitis. At age 37 he expired from adenocar- between 1970 and 1992. cinoma that metastasized to the liver. Literature review revealed only one possible case report of this PATIENT I; CASE HISTORY association with microscopic asymptomatic ulcerative colitis in that patient. Statistical analysis suggests that this association is Patient 1 presented at age 15 real rather than a chance occurrence. An autoimmune process years with a chief complaint of ab- may be involved and a specific histocompatibility locus antigen dominal pain and vomiting for 4 (HLA) type may exert a regulatory influence. months. He denied diarrhea, con- stipation, hematemesis, hemato- • INDEX TERMS: COLITIS, ULCERATIVE; CHOLANGITIS, SCLEROSING; DIABETES MEL- chezia, melena, fever, and joint, LITUS, INSULIN-DEPENDENT • CLEVE CLIN J MED 1993; 60:473-478 mouth, or skin problems. His medi- cal history was unremarkable. From the Section of Pediatric Gastroenterology and Nutrition, Family history revealed a maternal The Cleveland Clinic Foundation. Address reprint requests to R.W., Head, Section of Pediatric Gas- great uncle and a paternal aunt troenterology and Nutrition, Department of Pediatrics, A120, The with diabetes mellitus. Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, His local physician performed an OH 44195. upper gastrointestinal study with a small-bowel follow-through, which revealed thickening of the duode- nal sweep but was otherwise unre- NOVEMBER » DECEMBER 1993 CLEVELAND CLINIC JOURNAL OF MEDICINE 473 Downloaded from www.ccjm.org on October 1, 2021. For personal use only. All other uses require permission. ULCERATIVE COLITIS • KAY AND ASSOCIATES markable. He was treated with dicyclomine hydro- denoscopy revealed linear erosions in the gastric chloride and hydroxyzine hydrochloride without fundus. Colonoscopy demonstrated diffusely granu- symptomatic relief and was admitted to his local lar mucosa with punctate areas of hemorrhage from hospital. A blood workup revealed the following val- the rectum to the cecum consistent with ulcerative ues, with normal ranges in parentheses: an amylase colitis. Biopsy revealed diffuse chronic inflamma- level of 310 U/L (23 to 85 U/L), lipase 50IU/L (4 to tion with crypt abscess formation, and no granu- 24 IU/L), erythrocyte sedimentation rate 101 lomas. Endoscopic retrograde cholangiopancrea- mm/hour (0 to 15 mm/hour), platelet count 515 000 tography (ERCP) showed several areas of irregular (130 to 400 x 103), alkaline phosphatase 496 IU/mL filling in the common bile duct, common hepatic (50 to 136 IU/mL), alanine aminotransferase (ALT) duct, and intrahepatic ducts consistent with primary 96 IU (10 to 35 IU), aspartate aminotransferase 102 sclerosing cholangitis. The pancreatic duct was nor- IU (7 to 50 IU), total protein 10 g/dL (6 to 8 g/dL), mal. Repeat liver biopsy demonstrated expansion of and globulin 5.5 g/dL (2.3 to 3.5 g/dL). Ceruloplas- the portal tracts with a mixed acute and chronic min levels were normal. Hepatitis B surface antigen inflammatory infiltrate, fibrosis with focal areas of (HBsAg) and hepatitis B core antibody (anti-HBc) pseudo-bile-duct proliferation, hyalinization of con- were negative. Tests for antimitochondrial, antinu- nective tissues around preexisting bile ducts, slight clear factor, toxoplasmosis, and cytomegalovirus an- ballooning within the liver parenchyma, and bridg- tibodies were negative. Anti-smooth-muscle anti- ing between the portal tracts, consistent with body was positive, with a titer of 1:40 (reference: sclerosing cholangitis. negative). A liver scan and abdominal ultrasound The patient's condition was stabilized, and he was suggested a mass in the head of the pancreas. Com- discharged on sulfasalazine, 1 g bid. He did well, puterized tomography of the abdomen was normal. with a 30-kg weight gain, decreased stool frequency Exploratory laparotomy revealed intra-abdominal and abdominal pain, resolution of hematochezia, lymphadenopathy and a normal pancreas. Liver bi- and normalization of liver function tests. opsy performed during surgery showed widened por- He presented 3 years later with an 8-kg involun- tal tracts, portal edema and fibrosis, focal ductal pro- tary weight loss over 6 weeks, diminished energy, liferation, and neutrophilic infiltration of the bile polydipsia, and nocturia. He was admitted to the ducts. Several bile ducts were surrounded by lympho- hospital. Laboratory examination revealed urinaly- cytic and histiocytic infiltrates and dense fibrotic sis with 30 mg/dL glucose and trace ketones, blood tissue, consistent with primary sclerosing cholangitis. glucose values between 200 and 300 mg/dL (normal Patient 1 was subsequently referred to The range 65 to 110 mg/dL), elevated glycosylated he- Cleveland Clinic Foundation for further evaluation. moglobin 14.4% (3.5% to 6.5%), and a diminished Physical examination revealed a height at the 80th insulin level 2.5 |i.U/mL (4 to 24 fxU/mL); serum percentile and a weight at the 30th percentile. His electrolytes, complete blood count, and thyroid liver span was 7 cm with no lymphadenopathy. Rec- function tests were normal. tal exam was positive for occult blood. The physical His condition was stabilized on a regimen of regu- examination was otherwise unremarkable. Labora- lar and intermediate-acting insulin, and he was dis- tory studies demonstrated elevation of amylase to charged. Since discharge, he has regained his lost 533 IU (83% salivary origin) (normal range 10 to weight and his liver function tests have remained 135 U/L), and a Westergren sedimentation rate of normal. Histocompatibility locus antigen (HLA) 62 mm/hour (normal range 0 to 20 mm/hour); the testing was positive for the B8 and DR3 loci. ERCP alanine aminotransferase level and platelet count repeated 2 years later demonstrated irregularity of were mildly elevated. Aspartate aminotransferase the common bile duct with a short segmental irregu- and alkaline phosphatase values were normal. larity and stenosis of multiple intrahepatic ducts. Hepatitis A (anti-HAV), hepatitis B (HBsAg, anti- The cystic duct was normal. HBs), and antimitochondrial antibody studies were negative. Smooth muscle antibody studies were PATIENT 2: CASE HISTORY positive, with a titer of 1:10. Ultrasound of the gallbladder and pancreas re- The second patient was 19 when he presented to vealed a distended gallbladder without biliary duct our institution in 1970 with a complaint of loose dilation and a normal pancreas. Esophagogastroduo- bowel movements for 3 years. He had a 9-kg invol- 474 CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 60 • NUMBER 6 Downloaded from www.ccjm.org on October 1, 2021. For personal use only. All other uses require permission. ULCERATIVE COLITIS • KAY AND ASSOCIATES untary weight loss over 3 preceding months. A re- spite chemotherapy, he died 7 months later at age view of systems and his medical history were other- 37. HLA typing was not done. wise unremarkable. A family history revealed a cousin with diabetes mellitus. DISCUSSION Physical exam and vital signs were unremarkable. Proctosigmoidoscopy revealed patchy friability and The association of ulcerative colitis and sclerosing edema of the colonic mucosa; a barium enema study cholangitis has been well documented, but not in showed loss of haustral markings and mucosal pat- combination with insulin-dependent diabetes melli- tern. A regimen of sulfasalazine was started for the tus. We have been unable to find any reports linking ulcerative colitis. He gained weight, stool frequency these three disorders, either in the same patient or in diminished, and the proctosigmoidoscopic appear- first-degree relatives, and this was one of our reasons ance improved. for investigating the apparent association. Three months later he presented with polydipsia, Neither patient demonstrated convincing evi- polyuria, and involuntary weight loss. He was diag- dence of pancreatitis as the etiology of insulin-de- nosed as having diabetes mellitus, and a regimen of pendent
Recommended publications
  • Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis
    Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis National Digestive Diseases Information Clearinghouse What is microscopic colitis? The term bowel refers to any part of the small or large intestine. The large intes- Microscopic colitis is inflammation of the tine includes the colon and the rectum, and bowel that is only visible using a microscope. together they are about 5 feet long. The Microscopic colitis is a type of inflammatory U.S. Department small intestine can be 12 to 20 feet long. bowel disease (IBD), which refers to a group of Health and Colitis means inflammation of the colon. Human Services of conditions that causes inflammation in the Microscopic colitis is inflammation of the bowel due to an excessive build-up of white colon and rectum. NATIONAL blood cells in the bowel lining. Microscopic INSTITUTES OF HEALTH colitis is less severe than other types of IBD because it does not lead to cancer and rarely What are collagenous colitis requires surgery. However, microscopic and lymphocytic colitis? colitis can cause considerable pain and Microscopic colitis has two main forms: discomfort. collagenous colitis and lymphocytic colitis. The symptoms of and treatment for both are identical. Some scientists believe the two forms may be different presentations of the same disease. Slight differences in the way intestinal tissues appear when seen with a microscope set them apart. In both forms, an increase in white blood cells can be seen within the intestinal epithelium—the layer of Stomach Liver cells that lines the intestine. Increased white blood cells are a sign of inflammation. But with collagenous colitis, the layer of collagen Colon (shaded) beneath the epithelium appears thicker than normal.
    [Show full text]
  • Clinical and Pathological Aspects of Inflammatory Bowel Disease
    Inflammatory Bowel Diseases: B.R. Bistrian; J.A. Walker-Smith (eds), Nestlé Nutrition Workshop Series Clinical & Performance Programme, Vol. 2, pp. 83–92, Nestec Ltd.; Vevey/S. Karger AG, Basel, © 1999. Clinical and Pathological Aspects of Inflammatory Bowel Disease Ph. Marteau Gastroenterology Department, European Hospital Georges Pompidou, Paris, France The term “inflammatory bowel disease” applies to bowel diseases of unknown etiology characterized by chronic and often relapsing inflammation. They include ulcerative colitis, Crohn’s disease, indeterminate colitis, pouchitis, and micro- scopic colitides. Although these diseases share a number of epidemiological, pathological, and clinical features, they differ sufficiently to be classified as dis- tinct entities. The term “indeterminate colitis” is used for colitides which do not present enough criteria to be classified as ulcerative colitis or Crohn’s disease. Ulcerative Colitis Pathology Ulcerative colitis is a mucosal disease, which always affects the rectum and often also involves a variable contiguous proximal segment of colonic mucosa [1]. The lesions are continuous, and their upper limit is sharply demarcated from the normal mucosa above. They are limited to the rectum in about 25% of the patients (proctitis); reach the sigmoid colon in another 25% (proctosigmoiditis); spread to the splenic flexure in another 25% (left-sided colitis), and affect the whole colon in about 15% (pancolitis). The small intestine is usually normal but may be occasionally involved by superficial inflammation (“backwash ileitis”) in some patients with pancolitis. Macroscopic lesions can be evaluated during endoscopic examination [2]. Active lesions consist of edema, erythema, lack of the normal vascular pattern, bleeding, exudation of mucus or pus, and ulceration (Table 1).
    [Show full text]
  • Microscopic Colitis
    From Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden MICROSCOPIC COLITIS Marie-Rose Mellander Stockholm 2017 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Eprint AB 2017 © Marie-Rose Mellander, 2017 ISBN 978-91-7676-586-9 Microscopic colitis THESIS FOR DOCTORAL DEGREE (Ph.D.) By Marie-Rose Mellander Principal Supervisor: Opponent: Rolf Hultcrantz Marie Carlson Karolinska Institutet Uppsala University Department of Medicine, Huddinge Department of Medical Sciences; Gastroenterology/Hepatology Co-supervisors: Jan Björk Examination Board: Karolinska Institutet Catarina Almqvist Malmros Department of Medicine, Solna Karolinska Institutet Department of Medical Epidemiology and Robert Löfberg Biostatistics Karolinska Institutet Department of Medicine, Solna Kjell-Arne Ung University of Gothenburg Anders Ekbom Department of Medicine, Sahlgrenska Karolinska Institutet Department of Medicine, Solna Anders Höög Karolinska Institutet Department of Oncology-Pathology To my daughters Julia, Tilda and Sara ABSTRACT Microscopic colitis (MC) is an inflammatory bowel disease (IBD) and a common cause of chronic non-bloody diarrhoea, especially in elderly women. There are two main subtypes, lymphocytic colitis (LC) and collagenous colitis (CC) which are clinically indistinguishable and can be separated only by their characteristic histopathological features. The colonoscopy is usually macroscopically normal although subtle mucosal changes have been reported. The aetiology of MC is unknown and the genetic factors are poorly investigated. This thesis aims to describe MC in a large urban cohort and compare LC and CC regarding clinical and endoscopic features, both at diagnosis and at follow-up (F-U), and to observe the occurrence of coeliac disease, ulcerative colitis (UC) and Crohn’s disease (CD).
    [Show full text]
  • Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis
    A SPECIAL ARTICLE Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis Brennan A. Scott Thomas P. Prindiville Collagenous colitis and lymphocytic colitis are chronic relapsing diarrheal illnesses, which are often referred to together as microscopic colitis. It most commonly occurs in women in their fifth to sixth decade. The symptoms usually include profuse watery diarrhea and crampy abdominal pain. Laboratory and endoscopic studies are gener- ally normal but microscopic inflammation is seen when colonic biopsies are performed. In collagenous colitis there is a subepithelial collagen band in addition to chronic inflammation in the lamina propria. The etiology is not known but multiple theories exist including autoimmune, infectious, and medication-induced. Although the course is generally benign, patients may have multiple relapses over many years. Treatment regimens vary and have included anti-diarrheals, antibiotics, 5-aminosalicylates, steroids, and immunosuppressive agents. INTRODUCTION abdominal pain. Both conditions have normal mucosa ollagenous colitis (CC) (Figure 1) and lympho- when viewed endoscopically, however biopsy speci- cytic colitis (LC) (Figure 2) are uncommon mens show chronic mucosal inflammation. In CC C chronic relapsing diarrheal illnesses. The major- there is a subepithelial collagen band of varying thick- ity of patients are women in their fifth to sixth decade ness in association with an inflammatory cell infiltrate who complain of profuse, watery diarrhea, and crampy in the lamina propria (1). The collagen band is absent in LC (2,3). The term microscopic colitis (MC) was Brennan A. Scott, MD, Clinical Fellow, Division of Gas- originally used to describe patients with chronic diar- troenterology, University of California, Davis Medical rhea and normal endoscopic and barium enema stud- Center.
    [Show full text]
  • Microscopic Colitis Collagenous and Lymphocytic Colitis Publisher
    The informed patient Microscopic colitis Collagenous and lymphocytic colitis Publisher © 2020 Dr. Falk Pharma GmbH 6th updated and All rights reserved. revised edition 2020 The informed patient Microscopic colitis Collagenous and lymphocytic colitis Prof. Dr. Andreas Tromm, Hattingen (Germany) Microscopic colitis – Collagenous and lymphocytic colitis Address of the author Prof. Dr. Andreas Tromm Klinik für Innere Medizin Augusta-Kranken-Anstalt gGmbH Betriebsstelle EVK Hattingen Akademisches Lehrkrankenhaus der Universität Duisburg-Essen Bredenscheider Str. 54 45525 Hattingen Germany www.klinik-gastroenterologie.de Contents Introduction 4 Clinical presentation 6 Causes and development of microscopic colitis 9 Diagnosis 11 Treatment 14 Frequently asked questions about microscopic colitis 17 3 Microscopic colitis – Collagenous and lymphocytic colitis Introduction The term microscopic colitis encompasses two different disorders of the colon known as collagenous colitis and lymphocytic colitis. Both disorders are characterized by non-bloody watery diarrhea and are sometimes referred to as watery diar- rhea syndromes (Fig. 1). Microscopic colitis Collagenous colitis Lymphocytic colitis Watery diarrhea syndrome Fig. 1: Definition of microscopic colitis. 4 Introduction The term microscopic colitis describes a chronic in- flammatory disease of the colon (“colitis” comes from the Latin term “colon” and the ending “-itis”, which is used in medicine to refer to inflammation) that a doctor cannot identify by colonoscopy with the naked eye because the mucosa of the colon appears normal. In order for the disease to be diagnosed, the doctor must therefore remove a small tissue sample and examine it under a microscope. This is the only way to diagnose microscopic colitis. For collagenous colitis, a thickened collagen layer becomes visible when the tissue samples are stained using special methods, whereas lymphocytic colitis is detected as an increased number of a specific type of white blood cells called lymphocytes (see page 12).
    [Show full text]
  • Microscopic Colitis What Is Microscopic Colitis?
    Microscopic Colitis What is microscopic colitis? Microscopic colitis is an inflammation of the colon that a health care provider can see only with a microscope. Inflammation is the body’s normal response to injury, irritation, or infection of tissues. Microscopic colitis is a type of inflammatory bowel disease—the general name for diseases that cause irritation and inflammation in the intestines. The two types of microscopic colitis are collagenous colitis and lymphocytic colitis. Health care providers often use the term microscopic colitis to describe both types because their symptoms and treatments are the same. Some scientists believe that collagenous colitis and lymphocytic colitis may be different phases of the same condition rather than separate conditions. In both types of microscopic colitis, an increase in the number of lymphocytes, a type of white blood cell, can be seen in the epithelium—the layer of cells that lines the colon. An increase in the number of white blood cells is a sign of inflammation. The two types of colitis affect the colon tissue in slightly different ways: Lymphocytic colitis. The number of lymphocytes is higher, and the tissues and lining of the colon are of normal thickness. Collagenous colitis. The layer of collagen, a threadlike protein, underneath the epithelium builds up and becomes thicker than normal. When looking through a microscope, the health care provider may find variations in lymphocyte numbers and collagen thickness in different parts of the colon. These variations may indicate an overlap of the two types of microscopic colitis. What causes microscopic colitis? The exact cause of microscopic colitis is unknown.
    [Show full text]
  • Microscopic Colitis (PDF)
    INFORMATION SHEET MICROSCOPIC COLITIS INTRODUCTION Microscopic Colitis is an Inflammatory Bowel Disease (IBD) that affects the large bowel (colon and rectum). It isn’t always as well-recognised as Crohn’s Disease or Ulcerative Colitis, other forms of IBD. It can take to time to get a diagnosis of Microscopic Colitis. And dealing with watery poo, tummy cramps, and rushing to the toilet can all be hard to manage. But you’re not alone; we’re here to support you. Many people respond well to treatment and often symptoms go away when you find what’s right for you. If you’ve just been diagnosed or want to know more about Microscopic Colitis, this information is for you. WHAT IS MICROSCOPIC COLITIS Microscopic Colitis affects the part of the gut known as the large bowel – the colon and rectum. The large bowel, or colon’s main job is to absorb water from your poo, so you can pass a solid but soft and well-formed poo. THE GUT 1 OESOPHAGUS 2 STOMACH 1 3 SMALL BOWEL 2 4 COLON LARGE BOWEL 5 RECTUM} 6 ANUS 2 4 3 5 6 1 Crohn’s & Colitis UK | www.crohnsandcolitis.org.uk MICROSCOPIC COLITIS The walls of your bowel have layers. In Microscopic Colitis the inner lining becomes inflamed. But this change can only be seen when a sample of tissue (biopsy) is taken from your colon and looked at under a microscope. BOWEL LAYERS INNER LINING MIDDLE LAYER OUTER LAYER There are two types of Microscopic Colitis: • Lymphocytic Colitis (LC) – where the inner lining has more white blood cells (lymphocytes) than usual.
    [Show full text]
  • European Consensus on the Histopathology of Inflammatory Bowel Disease☆ F
    Journal of Crohn's and Colitis (2013) 7, 827–851 Available online at www.sciencedirect.com ScienceDirect CONSENSUS/GUIDELINES European consensus on the histopathology of inflammatory bowel disease☆ F. Magro a,⁎,1, C. Langner b,1, A. Driessen c, A. Ensari d, K. Geboes e, G.J. Mantzaris f, V. Villanacci g, G. Becheanu h, P. Borralho Nunes i, G. Cathomas j, W. Fries k, A. Jouret-Mourin l, C. Mescoli m, G. de Petris n, C.A. Rubio o, N.A. Shepherd p, M. Vieth q, R. Eliakim r on behalf of the European Society of Pathology (ESP) and the European Crohn's and Colitis Organisation (ECCO)2 a Department of Pharmacology & Therapeutics, Institute for Molecular and Cell Biology, Faculty of Medicine University of Porto, Department of Gastroenterology, Hospital de Sao Joao, Porto, Portugal b Institute of Pathology, Medical University of Graz, Austria c Department of Pathology, University Hospital Antwerp, Belgium d Department of Pathology, Ankara University Medical School, Turkey e Department of Pathology, UZ Leuven, Belgium f 1st Department of Gastroenterology, Evangelismos Hospital, Athens, Greece g Pathology, Spedali Civili, Brescia, Italy h Carol Davila University of Medicine and Pharmacy, Department of Pathology, Bucharest, Romania i Instituto de Anatomia Patologica, Escola Superior de Tecnologia da Saúde de Lisboa & Faculdade de Medicina da Universidade de Lisboa, Portugal j Institute for Pathology, Kanonsspital Baselland, Liestal, Switzerland k Dept. of Clinical and Experimental Medicine, Clinical Unit for Chronic Bowel Disorders, University of
    [Show full text]
  • Collagenous Gastritis: a Morphologic and Immunohistochemical Study of 40 Patients
    Modern Pathology (2015) 28, 533–544 & 2015 USCAP, Inc. All rights reserved 0893-3952/15 $32.00 533 Collagenous gastritis: a morphologic and immunohistochemical study of 40 patients Thomas Arnason1,2,10,, Ian S Brown3,4,10, Jeffrey D Goldsmith5, William Anderson6, Blake H O’Brien7, Claire Wilson8, Harland Winter9 and Gregory Y Lauwers1 1Gastrointestinal Pathology Service, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 2Division of Anatomical Pathology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada; 3Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia; 4Envoi Pathology, Brisbane, QLD, Australia; 5Department of Pathology, Children’s Hospital Boston, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 6GastroEnterology Associates of Ocala, Ocala, FL, USA; 7Sullivan Nicolaides Pathology, Brisbane, QLD, Australia; 8Providence Alaska Medical Center, Anchorage, AK, USA and 9Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA Collagenous gastritis is a rare condition defined histologically by a superficial subepithelial collagen layer. This study further characterizes the morphologic spectrum of collagenous gastritis by evaluating a multi- institutional series of 40 patients (26 female and 14 male). The median age at onset was 16 years (range 3–89 years), including 24 patients (60%) under age 18. Twelve patients (30%) had associated celiac disease, collagenous sprue, or collagenous colitis. Hematoxylin and eosin slides were reviewed in biopsies from all patients and tenascin, gastrin, eotaxin, and IgG4/IgG immunohistochemical stains were applied to a subset. The distribution of subepithelial collagen favored the body/fundus in pediatric patients and the antrum in adults. There were increased surface intraepithelial lymphocytes (425 lymphocytes/100 epithelial cells) in five patients.
    [Show full text]
  • Microscopic Colitis—Microbiome, Barrier Function and Associated Diseases
    Review Article Page 1 of 10 Microscopic colitis—microbiome, barrier function and associated diseases Saskia van Hemert1, Karolina Skonieczna-Żydecka2, Igor Loniewski2,3, Piotr Szredzki4, Wojciech Marlicz5 1Winclove Probiotics, Amsterdam, the Netherlands; 2Department of Biochemistry and Human Nutrition, Pomeranian Medical University, Szczecin, Poland; 3Sanprobi Sp. z o.o. Sp. K., Szczecin, Poland; 4Endoscopy Unit, Department of Surgery, Hospital Sędziszów Małopolski, Sędziszów Małopolski, Poland; 5Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland Contributions: (I) Conception and design: S van Hemert, W Marlicz; (II) Administrative support: None; (III) Provision of study materials or patients: K Żydecka-Skonieczna, I Loniewski; (IV) Collection and assembly of data: S van Hemert, K Żydecka-Skonieczna, W Marlicz; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Wojciech Marlicz, MD, PhD, FACG. Department of Gastroenterology, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland. Email: [email protected]. Abstract: Microscopic colitis (MC) is a chronic inflammatory bowel disease (IBD) with little in terms of endoscopic abnormalities and is frequently associated with other autoimmune diseases. The peak incidence of the disease is in middle aged or older populations, mostly females. The pathogenesis of MC is complex, multifactorial and poorly understood. Current concepts revolve around innate immunity or microbiome alterations as well as gut barrier dysfunction, all of which lead to the development of subtle inflammatory lesions in gut mucosa. The results of numerous basic and clinical studies involving molecular techniques as well as advanced endoscopic imaging revealed the important role of both intrinsic (e.g., hormonal) as well as extrinsic (e.g., NSAIDs and PPIs) factors in the modulation of gastrointestinal microbiome and MC pathogenesis.
    [Show full text]
  • Undiagnosed Microscopic Colitis: a Hidden Cause of Chronic Diarrhoea and a Frequently Missed Treatment Opportunity
    EDUCATION Frontline Gastroenterol: first published as 10.1136/flgastro-2019-101227 on 5 July 2019. Downloaded from REVIEW Undiagnosed microscopic colitis: a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity Andreas Münch ,1 David S Sanders,2 Michael Molloy- Bland,3 A Pali S Hungin4 1Division of Gastroenterology ABSTRACT patients and clinicians. In many national and Hepatology, Department Microscopic colitis (MC) is a treatable cause of Clinical and Experimental settings, because of downward pressure Medicine, Faculty of Health of chronic, non-bloody , watery diarrhoea, but to minimise specialist referrals and colo- Science, Linköping University, physicians (particularly in primary care) are less noscopies with histology in patients with Linköping, Sweden familiar with MC than with other causes of 2Department of seemingly normal endoscopic appear- Gastroenterology, Royal chronic diarrhoea. The colon in patients with ances, the systems for diagnosing and Hallamshire Hospital, Sheffield, MC is usually macroscopically normal. MC can managing patients with gastrointestinal UK only be diagnosed by histological examination 3Oxford PharmaGenesis, problems work against a diagnosis of MC Melbourne, Victoria, Australia of colonic biopsies (subepithelial collagen band and its effective management. 4 The Institute of Health and >10 µm (collagenous colitis) or >20 intraepithelial When first described in 1980, MC was Society, Faculty of Medical lymphocytes per 100 epithelial cells (lymphocytic 1 Sciences, Newcastle University, thought to be a rare condition. We now Newcastle upon Tyne, UK colitis), both with lamina propria inflammation). know that MC is a common form of inflam- The UK National Health Service exerts downward matory bowel disease (IBD), with one Correspondence to pressure to minimise colonoscopy referrals.
    [Show full text]
  • Collagenous Colitis
    Collagenous colitis Author: Doctor Fernando Fernández-Bañares1, Creation Date: July 2003 Update: February 2005 Scientific editor: Professor Jean-Alain Chayvialle 1Department of Gastroenterology, Hospital Universitari Mutua Terrassa, Plaza Dr Robert nº 5, 08221 Terrassa (Barcelona), Spain. [email protected] Abstract Key-words Disease name and synonyms Diagnosis criteria/definition Differential diagnosis Incidence Clinical description Management including treatment Etiology Diagnostic methods Unresolved questions References Abstract Collagenous colitis is characterized by chronic watery diarrhea, normal radiological and endoscopic appearances, and microscopic abnormalities in the colon. The specific histopathological feature is the presence of a subepithelial collagen band (10 µm or more) adjacent to the basal membrane, together with epithelial lymphocyte infiltration and chronic inflammation in lamina propria. A mean annual incidence of 0.6 to 6.1 per 100,000 inhabitants has been described, with a peak incidence in older women. The overall prognosis of the disease is good because cases with life-threatening diarrhea are extremely rare, and diarrhea subsides in almost all patients either spontaneously (near 20%) or with adequate therapy. Recent randomised placebo-controlled trials suggest that budesonide is an effective treatment for collagenous colitis inducing short-term clinical response in 57 to 87% of patients. However, relapse usually occurs early after stopping the drug, and thus maintenance therapy with low doses of budesonide is often required. Uncontrolled studies suggest that either mesalazine, cholestyramine, or bismuth subsalicylate are also effective. The etiology and pathogenesis of collagenous colitis are unknown. A mechanism based on genetic-predisposition, with some features of autoimmunity, initiated by a noxious agent(s) in the fecal stream, which would induce dysfunction of signal transmission between surface epithelium and subepithelial myofibroblasts generating abnormalities in collagen synthesis and/or degradation has been evoked.
    [Show full text]